Commodore Capital reported a 1.8% stake in Cogent Biosciences COGT · 2,802,905 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 1.8%
Last report: 7.2% · filed 25/11/14
Shares held: 2,802,905 sh
Class: Common Stock, $0.001 par value per share
Stock: Cogent Biosciences COGT
Holder: Commodore Capital
Event date: 25/12/31
Filed: 26/02/17

1.8% stake · below 5%

Stake: 1.8%
Last report: 7.2%
Since last report: −5.4pp

Cogent Biosciences trades, last 26 weeks

What else happened in Cogent Biosciences around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Commodore Capital's other 5% stake reports

Commodore Capital
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
Commodore Capital
5% stakeInflaRx
5% stake
InflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
Commodore Capital
5% stakePalisade Bio
5% stake
Palisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
Commodore Capital
5% stakeJatt II Acquisition
5% stake
Jatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
Commodore Capital
5% stakeRelay Therapeutics
5% stake
Relay Therapeutics
RLAY
5.5% stake
12,000,000 sh
5.5% stake
Filed 08/14